Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
NCT00355849
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
555
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Human Insulin Inhalation Powder
DRUG:
Insulin Glargine
Sponsor
Eli Lilly and Company
Collaborators
[object Object]